Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial
Download the PDF here.
This post appeared first on investingnews.com
Not For Distribution to U.S. News Wire Services or Dissemination in The United States Vancouver, BC, Dec. 20, 2024…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Brunswick Exploration Inc. (TSX-V:…
The US Federal Reserve announced an interest rate cut of 25 basis points on Wednesday (December 18), reducing its…
Mines and Money Miami, a key event for the mining industry, will take place on February 21-22, 2025, at…
(TheNewswire) TheNewswire – Troy Minerals Inc. (‘ Troy ‘ or the ‘ Company ‘ ) (CSE: TROY; OTCQB: TROYF;…
The uranium market entered 2024 on strong footing after a year of significant price movement, as well as renewed…
HIGHLIGHTS BBM trend now extends over 15km, from Awalé’s 100%-owned Fremen target in the south to the Boba and…
Investor and author Gianni Kovacevic shared his thoughts on copper market dynamics, saying that while the long-term trend is…